Works by Fernandez-Zarzoso, Miguel

Results: 7

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I.
Published in:
Basic & Clinical Pharmacology & Toxicology, 2018, v. 123, n. 1, p. 65, doi. 10.1111/bcpt.12977
By:
- Gras‐Colomer, Elena;
- Martínez‐Gómez, María‐Amparo;
- Climente‐Martí, Mónica;
- Fernandez‐Zarzoso, Miguel;
- Almela‐Tejedo, Mercedes;
- Giner‐Galvañ, Vicente;
- Marcos‐Rodríguez, Jose‐Antonio;
- Rodríguez‐Fernández, Alicia;
- Torralba‐Cabeza, Miguel‐Ángel;
- Merino‐Sanjuan, Matilde
Publication type:
Article
Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review.
Published in:
OncoTargets & Therapy, 2018, v. 11, p. 4583, doi. 10.2147/OTT.S141053
By:
- Donato, Eva M;
- Fernández-Zarzoso, Miguel;
- Hueso, Jose Antonio;
- de la Rubia, Javier
Publication type:
Article
Pellagra linked to maize consumption in Gambo, Ethiopia: A call for awareness.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 7, p. e617, doi. 10.1111/jdv.19829
By:
- Fernandez‐Gonzalez, Pablo;
- Seijas‐Pereda, Laura;
- Tefasmariam, Abraham;
- Balcha, Seble;
- Fernandez‐Zarzoso, Miguel;
- Onoda, Mamiko;
- Quiles‐Recuenco, Ana;
- Pérez‐Tanoira, Ramón;
- Malmierca, Eduardo
Publication type:
Article
Choroidal lymphoma diagnosed by polymerase chain reaction–based clonality assessment.
Published in:
European Journal of Ophthalmology, 2021, v. 31, n. 2, p. NP97, doi. 10.1177/1120672120911333
By:
- Hernández-Pons, Antonio;
- Gómez-Beltrán, Elena;
- Fernández-Zarzoso, Miguel;
- Albert-Fort, Mara;
- Martínez-Costa, Lucía
Publication type:
Article
Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment.
Published in:
2016
By:
- Gras-Colomer, Elena;
- Martínez-Gómez, María;
- Moya-Gil, Ana;
- Fernandez-Zarzoso, Miguel;
- Merino-Sanjuan, Matilde;
- Climente-Martí, Mónica;
- Martínez-Gómez, María Amparo;
- Climente-Martí, Mónica
Publication type:
journal article
Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study.
Published in:
Leukemia & Lymphoma, 2023, v. 64, n. 5, p. 913, doi. 10.1080/10428194.2023.2216327
By:
- Bravo, Julio;
- Baltasar Tello, Patricia;
- González Garcia, Esther;
- Ríos Herranz, Eduardo;
- Páyer, Angel Ramirez;
- Terol Castera, María José;
- Champ, Diana;
- Medina Perez, Angeles;
- Gironella, Mercedes;
- Fernández Zarzoso, Miguel;
- Forés, Rafael;
- Delgado, Julio;
- Garcia-Marco, José A.;
- Fernández, Alicia Rodríguez;
- Prat, Ana Muntañola;
- Cabrera, Alexia Suárez;
- Puerta Puerta, José Manuel;
- Rodríguez, Mercedes;
- Clavel, Juana;
- Dourdil Sahun, Maria Victoria
Publication type:
Article
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
Published in:
PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257353
By:
- González-Rincón, Julia;
- Garcia-Vela, José A.;
- Gómez, Sagrario;
- Fernández-Cuevas, Belén;
- Nova-Gurumeta, Sara;
- Pérez-Sanz, Nuria;
- Alcoceba, Miguel;
- González, Marcos;
- Anguita, Eduardo;
- López-Jiménez, Javier;
- González-Barca, Eva;
- Yáñez, Lucrecia;
- Pérez-Persona, Ernesto;
- de la Serna, Javier;
- Fernández-Zarzoso, Miguel;
- Deben, Guillermo;
- Peñalver, Francisco J.;
- Fernández, María C.;
- de Oteyza, Jaime Pérez;
- Andreu, M. Ángeles
Publication type:
Article

Works by Fernandez-Zarzoso, Miguel

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I.

Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review.

Pellagra linked to maize consumption in Gambo, Ethiopia: A call for awareness.

Choroidal lymphoma diagnosed by polymerase chain reaction–based clonality assessment.

Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment.

Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study.

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).